It’s actually a fairly light morning in analyst calls, particularly in medical and biotech shares. Here are four of the calls that we have seen so far this morning:
- Accuray (NASDAQ: ARAY) Cut to Sell from Neutral at UBS.
- Applied Biosystems (NYSE: ABI) Cut to Neutral from Buy at UBS.
- Mylan Labs (NYSE: MYL) started as Buy at Caris.
- PDL Biopharma (NASDAQ: PDLI) Cut to Neutral from Outperform at Credit Suisse.
Jon Ogg
June 13, 2008
